PEG-IL-10
Discussion Board › Forums › Clinical Trials › PEG-IL-10
- This topic has 7 replies, 3 voices, and was last updated 9 years, 10 months ago by msargent1.
-
AuthorPosts
-
February 12, 2015 at 3:01 am #86690msargent1Spectator
I think your response was fine Marion … no issues. I’ll certainly share any positive experiences!
So far, I think my dad’s treatments have been routine for MD Anderson. Sequencing didn’t show any identifiable mutations as the cause of the cancer, and he had 3 weeks of IMRT in December. My dad doesn’t appear to have to most aggressive form of the disease (mutations Dr. Javle talked about in the podcast), so I’m hopeful we can buy him time until better immunotherapy protocols are developed. I think these protocols will replace standard chemo in the next 5 to 10 years.
By the way, I can’t say enough positive things about MD Anderson and Dr. Javle!!! I know this is a tough diseases, and I am so thankful for the dedication and support of the people at that hospital!
February 11, 2015 at 4:12 pm #86689marionsModeratorMike…..I hope you did not misunderstand me. I applaud you on using this discussion board for the purpose of interacting with others in regards treatment experiences. This board, driven solely by the members, serves as a valuable resource to all touched by this cancer because of just that – the sharing of experiences with others in similar situations. We know that many so called “lurkers” (those that don’t sign up) gather much information from this site. If only they would join in and help us expand the knowledge base. In fact, if indeed you decide on participating in the mentioned trial, we will make sure to “sticky” (highlight) your thread.
It is unfortunate that study participants don’t have the means of interacting. It is prevented by HIPAA securing the healthcare information of all. The major downside in a clinical research study is the lack of knowledge and uncertainty of knowing how others respond in a likewise situation.It is likely that MD Anderson is the only cohort for Cholangiocarcinoma patients therefore; the information you share with us and the global community is of great value to all.
All my best wishes are heading your way with the upcoming visit.
Hugs,
MarionFebruary 11, 2015 at 2:22 pm #86688msargent1SpectatorMarion,
One person posted on the “Inspire” website, about the trial and their experiences, but they had to drop out of the trial because it wasn’t working for them. I believe they had lung cancer. I also emailed one of the “contacts” identified for the trial and was basically told Phase I had been expanded. Phase I was suppose (estimate) to have been completed in Dec 2014.
We meet with Dr. Javle in early March, so we’ll discuss this with him at that time … I was really just looking for people’s experience if they had been on the trial. I wanted to be prepared for that conversation.
Best regards
MikeFebruary 11, 2015 at 3:27 am #86687marionsModeratorMike…thanks much. You might not be able to connect with others as (I believe) accrual is in beginning stage. But, it won’t hurt to ask Dr. Javle as to how many people are participating as of now.
Hugs,
MarionFebruary 10, 2015 at 7:30 pm #86686gavinModeratorMany thanks for the link Mike.
Best wishes,
Gavin
February 10, 2015 at 6:42 pm #86685msargent1SpectatorFebruary 10, 2015 at 5:19 pm #86684marionsModeratormsargent……can you provide the link to the podcast?
Hugs
MarionFebruary 10, 2015 at 1:43 pm #10938msargent1SpectatorDr. Javle mentioned a trial utilizing PEG-IL-10, in one of MD Anderson’s podcasts. Has anyone had any experience with this drug … and if so, can you share?
-
AuthorPosts
- The forum ‘Clinical Trials’ is closed to new topics and replies.